Tecvayli and Intervertebral discitis - a phase IV clinical study of FDA data
Summary:
Intervertebral discitis is reported as a side effect among people who take Tecvayli (teclistamab-cqyv), especially for people who are female, 60+ old, also take Carfilzomib, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Intervertebral discitis when taking Tecvayli. It is created by eHealthMe based on reports of 664 people who have side effects when taking Tecvayli from the FDA, and is updated regularly.
What is Tecvayli?
Tecvayli has active ingredients of teclistamab-cqyv. eHealthMe is studying from 665 Tecvayli users. Check the latest studies of Tecvayli.
What is Intervertebral discitis?
Intervertebral discitis (infection in the intervertebral disc space) is found to be associated with 259 drugs and 330 conditions by eHealthMe. Check the latest studies of Intervertebral discitis.
664 people reported to have side effects when taking Tecvayli.
Among them, 11 people (1.66%) have Intervertebral discitis.

Among these 11 people:
What is the gender of people who have Intervertebral discitis when taking Tecvayli? *
- female: 100 %
- male: 0.0 %
What is the age of people who have Intervertebral discitis when taking Tecvayli? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Tecvayli? *
- Thalidomide: 11 people, 100.00%
- Platinol: 11 people, 100.00%
- Meloxicam: 11 people, 100.00%
- Etoposide: 11 people, 100.00%
- Dexamethasone: 11 people, 100.00%
- Carfilzomib: 11 people, 100.00%
- Cyclophosphamide: 10 people, 90.91%
What are other side effects people have besides Intervertebral discitis? *
- White Blood Cell Count Increased: 11 people, 100.00%
- Respiratory Tract Infection: 11 people, 100.00%
- Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 11 people, 100.00%
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 11 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Tecvayli and have Intervertebral discitis?
- Check whether Intervertebral discitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Tecvayli:
- Tecvayli (665 reports)
Intervertebral discitis treatments and more:
- Intervertebral discitis (3,246 reports)
How severe was Intervertebral discitis and when was it recovered:
Expand to all the drugs that have ingredients of teclistamab-cqyv:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tecvayli:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Intervertebral discitis:
- Intervertebral discitis (259 drugs)
Browse all the conditions that are associated with Intervertebral discitis:
- Intervertebral discitis (330 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on teclistamab-cqyv (the active ingredients of Tecvayli) and Tecvayli (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Mefenamic Acid and Naltrexone - 6 seconds ago
- Stilnoct vs. Flexeril, side effect and effectiveness comparison - 10 seconds ago
- Could Gemcitabine cause Eosinophil Count Decreased? - 16 seconds ago
- Could Abraxane cause Presyncope? - 31 seconds ago
- Drug interactions of Senna and Baby Aspirin - 31 seconds ago
- Drug interactions of Avodart and Insulin - 32 seconds ago
- Could Sandostatin cause Aura? - 32 seconds ago
- Cataplexy and Drug Withdrawal Syndrome - 38 seconds ago
- Could Flovent cause Hypotension? - 38 seconds ago
- Could Colace cause Pneumonitis Chemical? - 45 seconds ago